Cover Image
市場調查報告書

全球性感染疾病(STD)市場展望、新的機會

World Sexually-Transmitted Disease (STD) Diagnostics Market 2017-2022: Supplier Country Shares, Sales Segment Forecasts--Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis--Competitive Strategies, Innovative Technologies, Instrumentation

出版商 Venture Planning Group 商品編碼 323064
出版日期 內容資訊 英文 350 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球性感染疾病(STD)市場展望、新的機會 World Sexually-Transmitted Disease (STD) Diagnostics Market 2017-2022: Supplier Country Shares, Sales Segment Forecasts--Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis--Competitive Strategies, Innovative Technologies, Instrumentation
出版日期: 內容資訊: 英文 350 Pages
簡介

本報告提供美國,歐洲主要5個國家(法國、德國、義大利、西班牙、英國)及日本的性感染疾病市場相關研究、各國家、市場區隔的檢驗數、銷售額預測等。

第1章 簡介

第2章 全球市場及技術概要

  • 主要的傳染病檢查
    • 軟性下疳
      • 背景
      • 診斷檢驗
      • 疫苗及藥物
    • 披衣菌感染
    • 淋病
    • 單純皰疹病毒
    • 人類皰疹病毒6(HHV-6)
    • 乳突病毒(HPV)
    • 梅毒
  • 市售的主要分析儀的設備評估:Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac 及其他的供應商
  • 新興診斷技術
    • 分子診斷
    • 單株抗體
    • 免疫檢測法
    • 動態光散射法(DLS)
    • IT
    • 人工智能
    • 微脂體
    • 流式細胞技術
    • 層析法
    • 診斷影像
    • 凝膠微滴法 (GMD)
    • 其他

第3章 法國:市場規模、成長及主要供應商的銷售額及市場佔有率

第4章 德國:市場規模、成長及主要供應商的銷售額及市場佔有率

第5章 義大利:市場規模、成長及主要供應商的銷售額及市場佔有率

第6章 日本:市場規模、成長及主要供應商的銷售額及市場佔有率

第7章 西班牙:市場規模、成長及主要供應商的銷售額及市場佔有率

第8章 英國:市場規模、成長及主要供應商的銷售額及市場佔有率

第9章 美國:市場規模、成長及主要供應商的銷售額及市場佔有率

替代的市場滲透策略

  • 自家公司開發
  • 聯盟契約
  • 與大學的契約
  • 非集中檢驗市場流通策略
    • 行銷方法
    • 產品的複雜性
    • 客戶偏好
    • 現有供應商
    • 新興供應商
    • 主要經銷商的類型
    • 市場區隔

潛在市場進入障礙及風險

  • 市場成熟
  • 成本控制
  • 競爭
  • 技術力及限制
  • 專利保護
  • 法規限制
  • 非集中檢驗市場課題

競爭評估

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • 榮研化學
  • Enzo Biochem
  • FUJIREBIO
  • Gen-Probe
  • Hologic
  • ID Biomedical
  • Innogenetics/Solvay
  • Kreatech
  • Life Technology
  • Lonza
  • Nanogen/Elitech
  • Novartis Diagnostics
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • TaKaRa BIO
  • Thermo Fisher
  • Wallac
  • 和光純藥工業
  • 性感染疾病
  • 全球市場的展望、機會

圖表清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: VPID25285

About this Report

This report presents a detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan.  Current scientific views on epidemiology and etiology are presented for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.  The report provides test volume and sales forecasts by country and market segment, including:

     - Hospitals
     - Commercial/Private Labs
     - Physician Offices
     - Public Health Labs

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of STD diagnostic products, by test and country.  Also, the report:

     -  Examines market applications of Molecular Diagnostics,  
        Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;

     -  Reviews features and operating characteristics of major analyzers used
        for STD testing;

     -  Profiles key suppliers and potential market entrants developing innovative
        technologies and products; and

     -  Analyzes emerging opportunities, alternative market penetration strategies,
         market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U.S., five major European countries and Japan.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as VPGMarketResearch’s proprietary data files was conducted.

Contains 350 pages and 90 tables

 

Table of Contents

I. Introduction

II. Worldwide Market and Technology Overview

  • A. Major Infectious Disease Tests
    • 1. Chancroid
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 2. Chlamydia
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 3. Gonorrhea
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 4. Herpes Simplex Virus
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • Human Herpes Virus-6 (HHV-6)
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 5. Papillomavirus (HPV)
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 6. Syphilis
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
  • B. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
  • C. Emerging Diagnostic Technologies
    • 1. Molecular Diagnostics
    • 2. Monoclonal Antibodies
    • 3. Immunoassays
    • 4. Differential Light Scattering
    • 5. Information Technology
    • 6. Artificial Intelligence
    • 7. Liposomes
    • 8. Flow Cytometry
    • 9. Chromatography
    • 10. Diagnostic Imaging
    • 11. Gel Microdroplets
    • 12. Other

III. France: Market Size, Growth and Major Suppliers' Sales and Market Shares

IV. Germany: Market Size, Growth and Major Suppliers' Sales and Market Shares

V. Italy: Market Size, Growth and Major Suppliers' Sales and Market Shares

VI. Japan: Market Size, Growth and Major Suppliers' Sales and Market Shares

VII. Spain: Market Size, Growth and Major Suppliers' Sales and Market Shares

VIII. UK: Market Size, Growth and Major Suppliers' Sales and Market Shares

IX. USA: Market Size, Growth and Major Suppliers' Sales and Market Shares

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation

Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

Competitive Assessments

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Enzo Biochem
  • Fujirebio
  • Gen-Probe
  • Hologic
  • ID Biomedical
  • Innogenetics/Solvay
  • Kreatech
  • Life Technology
  • Lonza
  • Nanogen/Elitech
  • Novartis Diagnostics
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • Takara Bio
  • Thermo Fisher
  • Wallac
  • Wako
  • Sexually-Transmitted Diseases
  • Global Market Outlook and Opportunities

List of Tables

  • Major Companies Developing or Marketing Chlamydia Tests
  • Major Companies Developing or Marketing Gonorrhea Tests
  • Major Companies Developing or Marketing Herpes Tests
  • Major Companies Developing or Marketing Pap Smear/HPV Tests
  • Major Companies Developing or Marketing Syphilis Tests
  • France
  • Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
  • France
  • Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
  • France
  • Chlamydia Diagnostics Sales by Major Supplier
  • France
  • Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
  • France
  • Gonorrhea Testing Market Diagnostics Sales by Major Supplier
  • France
  • Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
  • France
  • Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
  • France
  • Herpes Testing Market Diagnostics Sales by Major Supplier
  • France
  • PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • France
  • Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • France
  • Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
  • France
  • Syphilis Testing Market Diagnostics Sales by Major Supplier
  • Germany
  • Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany
  • Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany
  • Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany
  • Gonorrhea Testing Market Diagnostics Sales by Major Supplier
  • Germany
  • Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany
  • Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany
  • Herpes Testing Market Diagnostics Sales by Major Supplier
  • Germany
  • PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany
  • Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany
  • Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy
  • Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy
  • Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy
  • Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy
  • Gonorrhea Testing Market Diagnostics Sales by Major Supplier
  • Italy
  • Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy
  • Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy
  • Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy
  • PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy
  • Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Chlamydia Diagnostics Sales by Major Supplier
  • Japan
  • Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Gonorrhea Testing Market Diagnostics Sales by Major Supplier
  • Japan
  • Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Herpes Testing Market Diagnostics Sales by Major Supplier
  • Japan
  • PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Syphilis Testing Market Diagnostics Sales by Major Supplier
  • Spain
  • Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain
  • Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain
  • Chlamydia Diagnostics Sales by Major Supplier
  • Spain
  • Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain
  • Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain
  • Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain
  • Herpes Testing Market Diagnostics Sales by Major Supplier
  • Spain
  • PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain
  • Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain
  • Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain
  • Syphilis Testing Market Diagnostics Sales by Major Supplier
  • U.K.
  • Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K.
  • Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K.
  • Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K.
  • Gonorrhea Testing Market Diagnostics Sales by Major Supplier
  • U.K.
  • Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K.
  • Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K.
  • Herpes Testing Market Diagnostics Sales by Major Supplier
  • U.K.
  • PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K.
  • Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K.
  • Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K.
  • Syphilis Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Chancroid Diagnostics Sales by Major Supplier
  • U.S.A.
  • Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Chlamydia Diagnostics Sales by Major Supplier
  • U.S.A.
  • Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Gonorrhea Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Herpes Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Syphilis Testing Market Diagnostics Sales by Major Supplier
Back to Top